Report - FILED PURSUANT TO RULE 425 - SEC.gov | HOME by Sanofi-Synthélabo Pursuant to Rule 425 under the United States Securities Act of 1933, as amended, and deemed filed pursuant to Rule

Please pass captcha verification before submit form